Siu Christine
CFO and Secretary at Eidos Therapeutics, Inc.
- Sold, on record
- $4.8M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Dec 9, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Eidos Therapeutics, Inc.CFO and Secretary
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Eidos Therapeutics, Inc.UnusualMar 19, 2019 2019
Sold 11,913 shares at $19.66 ($234k)
Siu Christine, CFO and Secretary
Sold 25.6% of holdings ($916k position)34,701 shares leftFirst sale on recordFiling
- 2 Form 4 sale Eidos Therapeutics, Inc.Plan not statedApr 24, 2019 +36 days
Sold 5,000 shares at $26.11 ($131k)
Siu Christine, CFO and Secretary
Sold 12.6% of holdings ($1M position)34,701 shares leftFiling
- 3 Form 4 sale Eidos Therapeutics, Inc.UnusualJun 5, 2019 +42 days
Sold 17,000 shares at $29.97 ($509k)
Siu Christine, CFO and Secretary
Sold 46.6% of holdings ($1.1M position)19,470 shares leftFiling
- 4 Form 4 sale Eidos Therapeutics, Inc.Plan not statedJul 10, 2019 +35 days
Sold 5,000 shares at $39.37 ($197k)
Siu Christine, CFO and Secretary
Sold 12.1% of holdings ($1.6M position)36,470 shares left0.4x usual sizeFiling
- 5 Form 4 sale Eidos Therapeutics, Inc.UnusualNov 22, 2019 +135 days
Sold 35,000 shares at $55.02 ($1.9M)
Siu Christine, CFO and Secretary
Sold 49% of holdings ($3.9M position)36,470 shares left4.1x usual sizeFiling
- 6 Form 4 sale Eidos Therapeutics, Inc.UnusualDec 4, 2019 +12 days
Sold 20,000 shares at $58.93 ($1.2M)
Siu Christine, CFO and Secretary
Sold 35.4% of holdings ($3.3M position)36,470 shares left1.7x usual sizeFiling
- 7 Form 4 sale Eidos Therapeutics, Inc.Plan not statedDec 9, 2019 +5 days
Sold 10,000 shares at $59.66 ($597k)
Siu Christine, CFO and Secretary
Sold 21.5% of holdings ($2.8M position)36,470 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2019 | Dec 11, 2019 | Eidos Therapeutics, Inc. | CFO and Secretary | Form 4 sale | 10,000 | $597k | 21.5% | Plan not stated | SEC |
| Dec 4, 2019 | Dec 5, 2019 | Eidos Therapeutics, Inc. | CFO and Secretary | Form 4 sale | 20,000 | $1.2M | 35.4% | Unusual | SEC |
| Nov 22, 2019 | Nov 22, 2019 | Eidos Therapeutics, Inc. | CFO and Secretary | Form 4 sale | 35,000 | $1.9M | 49.0% | Unusual | SEC |
| Jul 10, 2019 | Jul 12, 2019 | Eidos Therapeutics, Inc. | CFO and Secretary | Form 4 sale | 5,000 | $197k | 12.1% | Plan not stated | SEC |
| Jun 5, 2019 | Jun 7, 2019 | Eidos Therapeutics, Inc. | CFO and Secretary | Form 4 sale | 17,000 | $509k | 46.6% | Unusual | SEC |
| Apr 24, 2019 | Apr 26, 2019 | Eidos Therapeutics, Inc. | CFO and Secretary | Form 4 sale | 5,000 | $131k | 12.6% | Plan not stated | SEC |
| Mar 19, 2019 | Mar 21, 2019 | Eidos Therapeutics, Inc. | CFO and Secretary | Form 4 sale | 11,913 | $234k | 25.6% | Unusual | SEC |